🇺🇸 FDA
Patent

US 8604023

1,4-benzodiazepinone compounds and their use in treating cancer

granted A61PA61P35/00

Quick answer

US patent 8604023 (1,4-benzodiazepinone compounds and their use in treating cancer) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P35/00